MiRNA Signatures Related to Invasiveness and Recurrence in Patients With Non-Functioning Pituitary Neuroendocrine Tumors.

Emiliya Nikolova, Anelia Nankova, Silvia Kalenderova, Bilyana Georgieva, Asen Hadzhiyanev, Stoyan Bichev, Alexey Savov, Albena Todorova, Vanyo Mitev, Atanaska Elenkova
{"title":"MiRNA Signatures Related to Invasiveness and Recurrence in Patients With Non-Functioning Pituitary Neuroendocrine Tumors.","authors":"Emiliya Nikolova, Anelia Nankova, Silvia Kalenderova, Bilyana Georgieva, Asen Hadzhiyanev, Stoyan Bichev, Alexey Savov, Albena Todorova, Vanyo Mitev, Atanaska Elenkova","doi":"10.1055/a-2268-4129","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>This preliminary study aimed to analyze and identify differentially expressed miRNAs in Bulgarian patients with non-functioning pituitary neuroendocrine tumors (NFPitNET). The relationship between deregulated miRNAs and tumor invasiveness, recurrence, and size was determined.</p><p><strong>Methods: </strong>Twenty patients with NFPitNET were selected and fresh pituitary tumor tissues were collected. RNA containing miRNAs were isolated using miRNAeasy mini kit and analyzed by quantitative real-time polymerase chain reaction (PCR) using <i>LNA miRNA Cancer-</i>Focus <i>PCR</i> Panel (Qiagen).</p><p><strong>Results: </strong>Three miRNAs (miR-210-3p, miR-149-3p, and miR-29b-3p) were deregulated in invasive compared to non-invasive NFPitNETs. Differential expression of four-miRNA signatures - miRNA-17, miR-19, miR-106a, and miR-20, correlated with patient recurrence.</p><p><strong>Conclusion: </strong>This prospective pilot study selected a unique miRNA expression profile, that correlates with invasiveness and recurrence in non-functioning pituitary neuroendocrine tumors. Moreover, some of the selected miRNAs are reported for the first time in patients with this disease, shedding light on the molecular mechanisms involved in pituitary pathogenesis. The identified miRNAs demonstrate potential as biomarkers, deserving further investigation in a larger cohort to validate their clinical applicability.</p>","PeriodicalId":94001,"journal":{"name":"Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association","volume":" ","pages":"240-248"},"PeriodicalIF":0.0000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/a-2268-4129","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/14 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: This preliminary study aimed to analyze and identify differentially expressed miRNAs in Bulgarian patients with non-functioning pituitary neuroendocrine tumors (NFPitNET). The relationship between deregulated miRNAs and tumor invasiveness, recurrence, and size was determined.

Methods: Twenty patients with NFPitNET were selected and fresh pituitary tumor tissues were collected. RNA containing miRNAs were isolated using miRNAeasy mini kit and analyzed by quantitative real-time polymerase chain reaction (PCR) using LNA miRNA Cancer-Focus PCR Panel (Qiagen).

Results: Three miRNAs (miR-210-3p, miR-149-3p, and miR-29b-3p) were deregulated in invasive compared to non-invasive NFPitNETs. Differential expression of four-miRNA signatures - miRNA-17, miR-19, miR-106a, and miR-20, correlated with patient recurrence.

Conclusion: This prospective pilot study selected a unique miRNA expression profile, that correlates with invasiveness and recurrence in non-functioning pituitary neuroendocrine tumors. Moreover, some of the selected miRNAs are reported for the first time in patients with this disease, shedding light on the molecular mechanisms involved in pituitary pathogenesis. The identified miRNAs demonstrate potential as biomarkers, deserving further investigation in a larger cohort to validate their clinical applicability.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
与非功能性垂体神经内分泌肿瘤患者侵袭性和复发有关的 MiRNA 特征--一项在单一三级中心开展的试点研究。
目的:这项初步研究旨在分析和鉴定保加利亚非功能性垂体神经内分泌肿瘤(NFPitNET)患者体内表达不同的miRNA。研究还确定了失调的 miRNA 与肿瘤侵袭性、复发性和大小之间的关系:方法:选取 20 例非功能性垂体神经内分泌肿瘤患者,收集新鲜垂体肿瘤组织。用miRNAeasy mini试剂盒分离含有miRNA的RNA,并用LNA miRNA Cancer Focus PCR Panel(Qiagen公司)进行实时定量PCR分析:结果:与非侵袭性NFPitNET相比,侵袭性NFPitNET中有三个miRNA(miR-210-3p、miR-149-3p和miR-29b-3p)表达失调。四种miRNA特征--miRNA-17、miR-19、miR-106a和miR-20的差异表达与患者的复发有关:在这项前瞻性试验研究中,我们筛选出了与非功能性垂体神经内分泌肿瘤的侵袭性和复发相关的独特 miRNA 表达谱。此外,一些被选中的 miRNAs 还是首次在该病患者中被报道,从而揭示了垂体发病机制的分子机制。已鉴定的 miRNAs 具有作为生物标志物的潜力,值得在更大的群体中进一步研究,以验证其临床适用性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Novel Treatment Options in Patients with Maturity-Onset Diabetes of the Young. The mechanism and treatment of cognitive dysfunction in diabetes: A review. 21-Hydroxylase Deficiency Detected in Neonatal Screening: High Probability of False Negativity in Late Onset Form. Ocular motor mononeuropathies in diabetes mellitus: A brief review. Efficacy of Thyroid Hormone Replacement Therapy in Nasopharyngeal Carcinoma Patients with Radiation-Induced Subclinical Hypothyroidism.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1